A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF Application WO-2024052336-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF Application EP-4331602-A1 European Patent Office 06 Mar 2024
ADENOVIRUS VECTOR RECOMBINANT NOVEL CORONAVIRUS B.1.1.529 VARIANT VACCINE AND USE THEREOF Application WO-2023179009-A1 World Intellectual Property Organisation (WIPO) 28 Sep 2023
A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF Application WO-2023138770-A1 World Intellectual Property Organisation (WIPO) 27 Jul 2023
EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3… Application WO-2023091988-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
INDUCTION OF IMMUNITY TO SARS-COV-2 IN CHILDREN Application WO-2022197209-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086364-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086365-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
COMPOSITIONS AND METHODS TARGETING CORONAVIRUSES Application WO-2021201679-A1 World Intellectual Property Organisation (WIPO) 07 Oct 2021